| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | interleukin-1, type II receptor binding | 2.58e-05 | 2 | 102 | 2 | GO:0005151 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SPTAN1 ITGA3 ITGAV DST PTPRO NECTIN1 CGN GIGYF2 KIRREL1 MACF1 CTNNA2 SNX2 | 5.49e-05 | 599 | 102 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 5.63e-05 | 15 | 102 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 8.88e-05 | 46 | 102 | 4 | GO:0050997 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 2.06e-04 | 57 | 102 | 4 | GO:0120013 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.42e-04 | 321 | 102 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 2.42e-04 | 24 | 102 | 3 | GO:0120020 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 2.74e-04 | 25 | 102 | 3 | GO:0120015 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 3.09e-04 | 26 | 102 | 3 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 4.29e-04 | 29 | 102 | 3 | GO:0004629 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.11e-04 | 196 | 102 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | GTPase binding | 5.19e-04 | 360 | 102 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.03e-03 | 308 | 102 | 7 | GO:0008017 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.02e-04 | 384 | 101 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | lamellipodium | 1.27e-04 | 230 | 101 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | cell leading edge | 1.54e-04 | 500 | 101 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ABCA1 USP29 PTPN22 ITGA3 TSPAN1 CASK DST CCL2 KIRREL1 PLCG2 UGT2B28 COPS5 FKBP4 USP33 | 1.58e-04 | 934 | 101 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | axon | IL31RA SPTA1 SPTAN1 ITGA3 CHRM3 NEFL DST PTPRO NECTIN1 CCL2 CTNNA2 FKBP4 NIN | 3.57e-04 | 891 | 101 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | cell cortex | 4.39e-04 | 371 | 101 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | rod photoreceptor outer segment | 8.14e-04 | 9 | 101 | 2 | GO:0120200 | |
| GeneOntologyCellularComponent | spectrin | 8.14e-04 | 9 | 101 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.01e-03 | 10 | 101 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | growth cone | 1.22e-03 | 245 | 101 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | distal axon | 1.23e-03 | 435 | 101 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.44e-03 | 253 | 101 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.66e-03 | 354 | 101 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | cuticular plate | 1.74e-03 | 13 | 101 | 2 | GO:0032437 | |
| MousePheno | abnormal kidney cortex morphology | ABCA1 SPTA1 CEP290 PTPN22 NCF2 ITGA3 BBS10 PTPRO KIRREL1 PLCG2 BICC1 | 5.10e-06 | 324 | 87 | 11 | MP:0000521 |
| MousePheno | abnormal renal corpuscle morphology | ABCA1 SPTA1 PTPN22 NCF2 ITGA3 BBS10 PTPRO KIRREL1 PLCG2 BICC1 | 1.35e-05 | 293 | 87 | 10 | MP:0002827 |
| MousePheno | abnormal nephron morphology | ABCA1 SPTA1 CEP290 PTPN22 NCF2 ITGA3 BBS10 PTPRO KIRREL1 PLCG2 BICC1 | 6.45e-05 | 426 | 87 | 11 | MP:0003881 |
| Domain | Spectrin | 6.85e-06 | 23 | 102 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 1.79e-05 | 29 | 102 | 4 | IPR002017 | |
| Domain | SPEC | 2.68e-05 | 32 | 102 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.68e-05 | 32 | 102 | 4 | IPR018159 | |
| Domain | SH3 | 1.83e-04 | 216 | 102 | 7 | PS50002 | |
| Domain | SH3_domain | 2.05e-04 | 220 | 102 | 7 | IPR001452 | |
| Domain | - | 4.37e-04 | 6 | 102 | 2 | 3.90.1290.10 | |
| Domain | GAR | 4.37e-04 | 6 | 102 | 2 | PS51460 | |
| Domain | EFhand_Ca_insen | 4.37e-04 | 6 | 102 | 2 | PF08726 | |
| Domain | GAS2 | 4.37e-04 | 6 | 102 | 2 | PF02187 | |
| Domain | EF-hand_Ca_insen | 4.37e-04 | 6 | 102 | 2 | IPR014837 | |
| Domain | - | 4.37e-04 | 6 | 102 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 4.37e-04 | 6 | 102 | 2 | IPR003108 | |
| Domain | GAS2 | 4.37e-04 | 6 | 102 | 2 | SM00243 | |
| Domain | Plectin | 6.09e-04 | 7 | 102 | 2 | PF00681 | |
| Domain | Plectin_repeat | 6.09e-04 | 7 | 102 | 2 | IPR001101 | |
| Domain | PLEC | 6.09e-04 | 7 | 102 | 2 | SM00250 | |
| Domain | PTPc | 9.91e-04 | 36 | 102 | 3 | SM00194 | |
| Domain | EF-hand-dom_pair | 1.00e-03 | 287 | 102 | 7 | IPR011992 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.25e-03 | 39 | 102 | 3 | PS50055 | |
| Domain | PTPase_domain | 1.45e-03 | 41 | 102 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.45e-03 | 41 | 102 | 3 | PF00102 | |
| Domain | ABC_A | 1.88e-03 | 12 | 102 | 2 | IPR026082 | |
| Domain | SH3_1 | 2.06e-03 | 164 | 102 | 5 | PF00018 | |
| Domain | P-loop_NTPase | ABCA1 ERCC3 ERCC6 ABCA13 DNAH2 MCM6 MSH3 DHX33 CASK SAMD9L PARPBP RAB13 | 2.25e-03 | 848 | 102 | 12 | IPR027417 |
| Domain | - | ABCA1 ERCC3 ERCC6 ABCA13 DNAH2 MCM6 MSH3 DHX33 CASK SAMD9L RAB13 | 2.51e-03 | 746 | 102 | 11 | 3.40.50.300 |
| Domain | EF-hand_like | 2.96e-03 | 15 | 102 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 2.96e-03 | 15 | 102 | 2 | PF00387 | |
| Domain | PLCYc | 2.96e-03 | 15 | 102 | 2 | SM00149 | |
| Domain | Spectrin_alpha_SH3 | 2.96e-03 | 15 | 102 | 2 | IPR013315 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.96e-03 | 15 | 102 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 2.96e-03 | 15 | 102 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 2.96e-03 | 15 | 102 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.96e-03 | 15 | 102 | 2 | IPR015359 | |
| Domain | - | 3.09e-03 | 261 | 102 | 6 | 1.10.238.10 | |
| Domain | Integrin_alpha_C_CS | 3.37e-03 | 16 | 102 | 2 | IPR018184 | |
| Domain | PTPc_motif | 4.12e-03 | 59 | 102 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 4.12e-03 | 59 | 102 | 3 | IPR003595 | |
| Domain | Integrin_alpha-2 | 4.27e-03 | 18 | 102 | 2 | IPR013649 | |
| Domain | PI-PLC-X | 4.27e-03 | 18 | 102 | 2 | PF00388 | |
| Domain | INTEGRIN_ALPHA | 4.27e-03 | 18 | 102 | 2 | PS00242 | |
| Domain | PLCXc | 4.27e-03 | 18 | 102 | 2 | SM00148 | |
| Domain | Integrin_alpha2 | 4.27e-03 | 18 | 102 | 2 | PF08441 | |
| Domain | Integrin_alpha | 4.27e-03 | 18 | 102 | 2 | IPR000413 | |
| Domain | Int_alpha | 4.75e-03 | 19 | 102 | 2 | SM00191 | |
| Domain | Int_alpha_beta-p | 4.75e-03 | 19 | 102 | 2 | IPR013519 | |
| Domain | PIPLC_X_DOMAIN | 4.75e-03 | 19 | 102 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.75e-03 | 19 | 102 | 2 | IPR000909 | |
| Pubmed | POMGNT1 SLC39A10 COG3 ITGAV PIK3R4 DST ZFYVE9 LRIG1 SUN2 EMC2 SNX2 USP33 | 3.13e-08 | 504 | 102 | 12 | 34432599 | |
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 21406181 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | APOB ITGA3 SLC39A10 CASK PTPRG NECTIN1 KIRREL1 FGD6 RAB13 IPMK ARAP2 | 9.49e-07 | 569 | 102 | 11 | 30639242 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RANBP3 SPTAN1 PIK3R4 KIAA1671 DST TCERG1 CGN GIGYF2 MACF1 FGD6 SNX2 BICC1 ARAP2 | 1.48e-06 | 861 | 102 | 13 | 36931259 |
| Pubmed | SPTAN1 CEP290 PTPN22 SLC39A10 CASK KIAA1671 NEFL ZFYVE9 PTPRG SUN2 CGN KIRREL1 FKBP4 NIN | 2.39e-06 | 1049 | 102 | 14 | 27880917 | |
| Pubmed | alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. | 3.02e-06 | 34 | 102 | 4 | 16889989 | |
| Pubmed | ZHX3 CCDC30 CEP290 MSH3 PP2D1 CHRNA1 SAMD9L GOLPH3L FGD6 SNX2 BICC1 | 5.69e-06 | 686 | 102 | 11 | 29987050 | |
| Pubmed | 6.12e-06 | 560 | 102 | 10 | 35241646 | ||
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 6.86e-06 | 13 | 102 | 3 | 17920017 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18031309 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11002341 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28694219 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24269887 | ||
| Pubmed | Binding of brain spectrin to the 70-kDa neurofilament subunit protein. | 8.52e-06 | 2 | 102 | 2 | 3121319 | |
| Pubmed | αII-spectrin regulates invadosome stability and extracellular matrix degradation. | 8.52e-06 | 2 | 102 | 2 | 25830635 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21951843 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20926544 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30076206 | ||
| Pubmed | Integrators of the cytoskeleton that stabilize microtubules. | 8.52e-06 | 2 | 102 | 2 | 10428034 | |
| Pubmed | 8.80e-06 | 347 | 102 | 8 | 17114649 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ERCC3 ERCC6 SPTAN1 MCM6 MSH3 DHX33 NMD3 PIK3R4 NAA35 DST TCERG1 MACF1 AKAP10 PLCG2 RAB13 | 9.54e-06 | 1353 | 102 | 15 | 29467282 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.22e-05 | 363 | 102 | 8 | 14691545 | |
| Pubmed | 1.37e-05 | 486 | 102 | 9 | 20936779 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | IL31RA POMGNT1 APOB ITGA3 COG3 PDE4DIP RBM5 MACF1 CTNNA2 EMC2 RAB13 SNX2 BICC1 | 1.40e-05 | 1061 | 102 | 13 | 33845483 |
| Pubmed | MCM6 ECPAS CASK KIAA1671 NEFL TCERG1 CGN RBM5 FGD6 FKBP4 ARAP2 SOS1 | 1.60e-05 | 916 | 102 | 12 | 32203420 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.60e-05 | 377 | 102 | 8 | 38117590 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.94e-05 | 18 | 102 | 3 | 12119179 | |
| Pubmed | 2.10e-05 | 513 | 102 | 9 | 25798074 | ||
| Pubmed | SPTAN1 CEP290 MSH3 CASK PIK3R4 NEFL DST TCERG1 PDE4DIP MACF1 DNAI7 COPS5 USP33 SOS1 | 2.36e-05 | 1285 | 102 | 14 | 35914814 | |
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 2.55e-05 | 3 | 102 | 2 | 12399109 | |
| Pubmed | Human Adenovirus Type 37 Uses αVβ1 and α3β1 Integrins for Infection of Human Corneal Cells. | 2.55e-05 | 3 | 102 | 2 | 27974569 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 26784654 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20890423 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 30694837 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 21530503 | ||
| Pubmed | Interaction domains of neurofilament light chain and brain spectrin. | 2.55e-05 | 3 | 102 | 2 | 1902666 | |
| Pubmed | CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration. | 2.55e-05 | 3 | 102 | 2 | 23845726 | |
| Pubmed | Mass spectrometric based mapping of the disulfide bonding patterns of integrin alpha chains. | 2.55e-05 | 3 | 102 | 2 | 14596610 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 16679515 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22566688 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19268428 | ||
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 2.55e-05 | 3 | 102 | 2 | 2971657 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 33651148 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11877431 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24534280 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10069334 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 15604518 | ||
| Pubmed | 2.76e-05 | 407 | 102 | 8 | 12693553 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 4.44e-05 | 565 | 102 | 9 | 25468996 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 21779326 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 8921257 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 10551855 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23402987 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 35192681 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 1828262 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 16731529 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 12571280 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26158606 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 14666169 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 16874800 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 9593709 | ||
| Pubmed | p53 modulation of TFIIH-associated nucleotide excision repair activity. | 5.09e-05 | 4 | 102 | 2 | 7663514 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 31302159 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 5.09e-05 | 4 | 102 | 2 | 3862089 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 21182210 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 8954775 | ||
| Pubmed | Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2. | 5.09e-05 | 4 | 102 | 2 | 12049649 | |
| Pubmed | Morphofunctional studies of the glomerular wall in mice lacking entactin-1. | 5.09e-05 | 4 | 102 | 2 | 14566019 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 22163289 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 10721695 | ||
| Pubmed | The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins. | 5.09e-05 | 4 | 102 | 2 | 15361064 | |
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 5.09e-05 | 4 | 102 | 2 | 12820899 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 28865324 | ||
| Pubmed | 5.26e-05 | 446 | 102 | 8 | 24255178 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 5.37e-05 | 25 | 102 | 3 | 8493579 | |
| Pubmed | 5.50e-05 | 225 | 102 | 6 | 12168954 | ||
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 6.07e-05 | 229 | 102 | 6 | 19948975 | |
| Pubmed | 6.27e-05 | 591 | 102 | 9 | 15231748 | ||
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 6.68e-05 | 233 | 102 | 6 | 32290105 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SPTAN1 MCM6 APOB MSH3 ECPAS NMD3 PIK3R4 TCERG1 RBM5 GIGYF2 EMC2 MED23 FKBP4 SNX2 | 7.21e-05 | 1425 | 102 | 14 | 30948266 |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 7.31e-05 | 146 | 102 | 5 | 20686565 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ERCC3 RIPK1 CEP290 SLC39A10 ECPAS SUN2 PDE4DIP GIGYF2 EMC2 NIN | 7.66e-05 | 754 | 102 | 10 | 33060197 |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 11025210 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 10706702 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 18356535 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 9971739 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 23533167 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 16034137 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 24124408 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 3027087 | ||
| Pubmed | Vertebrate Dynein-f depends on Wdr78 for axonemal localization and is essential for ciliary beat. | 8.47e-05 | 5 | 102 | 2 | 30060180 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 16336193 | ||
| Pubmed | 8.57e-05 | 151 | 102 | 5 | 17043677 | ||
| Pubmed | 9.55e-05 | 360 | 102 | 7 | 33111431 | ||
| Pubmed | CCDC30 APOB SLC39A10 CASK KIAA1671 DST RBM5 KIRREL1 SDK1 ARAP2 | 9.80e-05 | 777 | 102 | 10 | 35844135 | |
| Pubmed | 1.07e-04 | 634 | 102 | 9 | 34591612 | ||
| Pubmed | ERAP1 SPTAN1 APOB ITGA3 GALNT7 ITGAV NAA35 DST MACF1 HACL1 CTNNA2 FKBP4 RAB13 | 1.09e-04 | 1297 | 102 | 13 | 33545068 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.11e-04 | 497 | 102 | 8 | 36774506 | |
| Pubmed | RANBP3 SPTAN1 SLC39A10 NDUFS4 CASK NAA35 SUN2 KIRREL1 MACF1 EMC2 FKBP4 SNX2 USP33 NIN | 1.13e-04 | 1487 | 102 | 14 | 33957083 | |
| Interaction | MAPRE1 interactions | ERCC6 SPTAN1 CEP290 MCM6 CASK PIK3R4 DST PDE4DIP GIGYF2 MACF1 COPS5 NIN | 1.12e-05 | 514 | 102 | 12 | int:MAPRE1 |
| Interaction | RND2 interactions | SPTAN1 MCM6 SLC39A10 ITGAV CASK DST ZFYVE9 PTPRG SUN2 KIRREL1 EMC2 | 1.42e-05 | 440 | 102 | 11 | int:RND2 |
| Interaction | CYP2J2 interactions | 1.53e-05 | 30 | 102 | 4 | int:CYP2J2 | |
| Interaction | HRAS interactions | SPTA1 SPTAN1 USP29 APOB ITGA3 SLC39A10 ECPAS NECTIN1 KIRREL1 FGD6 RAB13 ARAP2 PLCE1 SOS1 | 1.71e-05 | 725 | 102 | 14 | int:HRAS |
| Interaction | GJA1 interactions | SPTAN1 APOB SLC39A10 CASK PIK3R4 DST ZFYVE9 PTPRG KIRREL1 MACF1 SDK1 ARAP2 | 3.87e-05 | 583 | 102 | 12 | int:GJA1 |
| Interaction | ARF6 interactions | SLC39A10 COG3 ECPAS CHRM3 CASK ZFYVE9 PTPRG PDE4DIP KIRREL1 FKBP4 SNX2 ARAP2 | 3.94e-05 | 584 | 102 | 12 | int:ARF6 |
| Interaction | OCLN interactions | SPTAN1 SLC39A10 CASK KIAA1671 DST ZFYVE9 PTPRG CGN KIRREL1 MACF1 ARAP2 | 4.58e-05 | 500 | 102 | 11 | int:OCLN |
| Interaction | RHOU interactions | SPTAN1 MCM6 SLC39A10 ITGAV NMD3 CASK DST PTPRG KIRREL1 MACF1 EMC2 | 5.47e-05 | 510 | 102 | 11 | int:RHOU |
| Interaction | DIRAS3 interactions | 5.61e-05 | 262 | 102 | 8 | int:DIRAS3 | |
| Interaction | RHOH interactions | SPTAN1 MCM6 SLC39A10 ITGAV CASK DST PTPRG SUN2 KIRREL1 EMC2 SNX2 | 5.67e-05 | 512 | 102 | 11 | int:RHOH |
| Interaction | H2BC9 interactions | 8.83e-05 | 446 | 102 | 10 | int:H2BC9 | |
| Interaction | LAMP1 interactions | SPTAN1 ITGA3 SLC39A10 ITGAV CASK DST ZFYVE9 PTPRG KIRREL1 MACF1 EMC2 RAB13 | 1.00e-04 | 644 | 102 | 12 | int:LAMP1 |
| Interaction | SPTA1 interactions | 1.16e-04 | 94 | 102 | 5 | int:SPTA1 | |
| Interaction | ABI1 interactions | 1.40e-04 | 223 | 102 | 7 | int:ABI1 | |
| Interaction | FLOT1 interactions | ABCA1 SPTAN1 SLC39A10 ECPAS CASK DST ZFYVE9 KIRREL1 MACF1 NIN | 1.48e-04 | 475 | 102 | 10 | int:FLOT1 |
| Interaction | RAB7A interactions | POMGNT1 SLC39A10 COG3 ITGAV PIK3R4 DST ZFYVE9 LRIG1 SUN2 EMC2 COPS5 RAB13 SNX2 USP33 | 1.48e-04 | 886 | 102 | 14 | int:RAB7A |
| Interaction | RHOF interactions | SPTAN1 MSH3 SLC39A10 ECPAS ITGAV NMD3 CASK PTPRG SUN2 KIRREL1 MACF1 EMC2 | 1.51e-04 | 673 | 102 | 12 | int:RHOF |
| Interaction | TMOD1 interactions | 1.69e-04 | 161 | 102 | 6 | int:TMOD1 | |
| Interaction | C11orf52 interactions | 1.84e-04 | 311 | 102 | 8 | int:C11orf52 | |
| Interaction | PLTP interactions | 1.86e-04 | 56 | 102 | 4 | int:PLTP | |
| GeneFamily | EF-hand domain containing|Spectrins | 4.00e-04 | 7 | 80 | 2 | 1113 | |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 4.00e-04 | 7 | 80 | 2 | 1268 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.32e-04 | 8 | 80 | 2 | 939 | |
| GeneFamily | ATP binding cassette subfamily A | 1.70e-03 | 14 | 80 | 2 | 805 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.83e-03 | 18 | 80 | 2 | 1160 | |
| GeneFamily | EF-hand domain containing | 2.87e-03 | 219 | 80 | 5 | 863 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.15e-03 | 19 | 80 | 2 | 832 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.84e-03 | 21 | 80 | 2 | 813 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 3.84e-03 | 21 | 80 | 2 | 980 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.43e-03 | 25 | 80 | 2 | 775 | |
| GeneFamily | Fibronectin type III domain containing | 5.55e-03 | 160 | 80 | 4 | 555 | |
| GeneFamily | Sterile alpha motif domain containing | 6.99e-03 | 88 | 80 | 3 | 760 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 MSH3 CASK PIK3R4 DST ZFYVE9 LRIG1 GIGYF2 MACF1 AKAP10 DENND5A EMC2 SNX2 ARAP2 PLCE1 SOS1 | 2.00e-07 | 856 | 102 | 16 | M4500 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 8.14e-06 | 437 | 102 | 10 | M4665 | |
| Coexpression | GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN | 1.36e-05 | 200 | 102 | 7 | M4338 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.55e-07 | 174 | 102 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 2.03e-07 | 181 | 102 | 7 | 921e917f83105896ad8918dc134b871708024021 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 102 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 102 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 102 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-07 | 187 | 102 | 7 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.72e-07 | 189 | 102 | 7 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 192 | 102 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-07 | 194 | 102 | 7 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | BAL-Mild-Myeloid-TRAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.86e-07 | 199 | 102 | 7 | 8a31a459491aa8625802c5211d38d57c1e8be76b | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.86e-07 | 199 | 102 | 7 | 4e518651ff219e163cfd9deb58566df6308aa3f7 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM3|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.86e-07 | 199 | 102 | 7 | 4ab5da8ab757e8294c743949a5374b6e6a388913 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.86e-07 | 199 | 102 | 7 | af167e7a16c3537ce0aa821f608cdcb0c3abc07f | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.86e-07 | 199 | 102 | 7 | 4b88ce864dc75ed8596a076ce4498f73639bbac8 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.86e-07 | 199 | 102 | 7 | bae7aa25f9e23fea19371390b8306e9dc3e4d549 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.99e-07 | 200 | 102 | 7 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 154 | 102 | 6 | 27f76e4b3c055aa382708f1610c685f02d6d6114 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 154 | 102 | 6 | 8746663a822d93a8510081c81a8c971b51653067 | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 168 | 102 | 6 | 749eccebe4ee066f827d2a3980512f195f23ac27 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intermediate_macrophages|Liver / Manually curated celltypes from each tissue | 2.75e-06 | 171 | 102 | 6 | 25e0333743affdb662223fb5220b8a61fa02ad9f | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 175 | 102 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 3.25e-06 | 176 | 102 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.69e-06 | 180 | 102 | 6 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.19e-06 | 184 | 102 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.19e-06 | 184 | 102 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 185 | 102 | 6 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 185 | 102 | 6 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 185 | 102 | 6 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.60e-06 | 187 | 102 | 6 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-06 | 189 | 102 | 6 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.89e-06 | 189 | 102 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-06 | 189 | 102 | 6 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 190 | 102 | 6 | 92710caaff05123cf8e909319d7ac441d9b31a66 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 5.04e-06 | 190 | 102 | 6 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.19e-06 | 191 | 102 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 192 | 102 | 6 | ef0aba777072429a6ab7dcfcc305673975946580 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-06 | 193 | 102 | 6 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.51e-06 | 193 | 102 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.68e-06 | 194 | 102 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.68e-06 | 194 | 102 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.68e-06 | 194 | 102 | 6 | 6b48383151b678489bcd6133d389a5d8b3a50186 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.68e-06 | 194 | 102 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-06 | 195 | 102 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-06 | 195 | 102 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | VE-granulo1-|VE / Condition, Cell_class and T cell subcluster | 6.02e-06 | 196 | 102 | 6 | ab3f2ce294c7e503d86254a195be0cf500a2c5e4 | |
| ToppCell | VE-granulo1|VE / Condition, Cell_class and T cell subcluster | 6.02e-06 | 196 | 102 | 6 | 6dbd3acb30173d7f0b7bca0a82f435f00ca85835 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.20e-06 | 197 | 102 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.20e-06 | 197 | 102 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-06 | 197 | 102 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-06 | 197 | 102 | 6 | 01f5f5c34e904cc0146e978cc05ed1cd86a41533 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-06 | 198 | 102 | 6 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.57e-06 | 199 | 102 | 6 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | BAL-Mild-Myeloid-TRAM|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-06 | 199 | 102 | 6 | 27c63da6b29a1fc57ed2568443ba5029f3cdb186 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 6.57e-06 | 199 | 102 | 6 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.57e-06 | 199 | 102 | 6 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.57e-06 | 199 | 102 | 6 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.57e-06 | 199 | 102 | 6 | 6783d571d28eac891fcc70380f176b53f35c88ba | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.76e-06 | 200 | 102 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.76e-06 | 200 | 102 | 6 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.76e-06 | 200 | 102 | 6 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.76e-06 | 200 | 102 | 6 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.76e-06 | 200 | 102 | 6 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-05 | 141 | 102 | 5 | b5e85f89b930a0ec70cc95733c5ab76ac3e9497f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 148 | 102 | 5 | bbf4933582b50b3412c805de5ed137107c996236 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 148 | 102 | 5 | 6543860e3207a7de92a35bb6004be51287582f7a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 148 | 102 | 5 | 79e376503a3f9504a1ec5af4a60a09cc80e19059 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 152 | 102 | 5 | 962f5bf632da79bd933193d3edd7d89941a85831 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 155 | 102 | 5 | afdd0aba0f3788c2fb916ffb453c5dd7cde2304c | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 162 | 102 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 164 | 102 | 5 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 168 | 102 | 5 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 168 | 102 | 5 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.25e-05 | 168 | 102 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 168 | 102 | 5 | 02dfe8037e61f9d4ac5f8df3929673bc212fd2cd | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 168 | 102 | 5 | 94916feefd413c84bb7d3fd2d3e403036b705b69 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 168 | 102 | 5 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 168 | 102 | 5 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | 7a7416fcbffcf57d19b477d9da091e04e3499524 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | 0e1a99cd77edcf32bcb513abd247b2b27409ac63 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | 9bbad31ef03078f5aa456f2e1b17b49c91545ff0 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.63e-05 | 171 | 102 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.76e-05 | 172 | 102 | 5 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 172 | 102 | 5 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 173 | 102 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 4.89e-05 | 173 | 102 | 5 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 173 | 102 | 5 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-05 | 175 | 102 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 5.45e-05 | 177 | 102 | 5 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 177 | 102 | 5 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 178 | 102 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.60e-05 | 178 | 102 | 5 | fbf49766e1504df554856b84c0576c06f3167329 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-05 | 179 | 102 | 5 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-05 | 179 | 102 | 5 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-05 | 181 | 102 | 5 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 6.06e-05 | 181 | 102 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.22e-05 | 182 | 102 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 182 | 102 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.38e-05 | 183 | 102 | 5 | aed12b743334f3813db0c70d4fe7df90e0673f54 | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 6.38e-05 | 183 | 102 | 5 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-05 | 183 | 102 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; HL60; HG-U133A | 3.21e-06 | 199 | 102 | 8 | 1436_UP | |
| Drug | Harzol | 9.35e-06 | 63 | 102 | 5 | CID000006744 | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; HL60; HT_HG-U133A | 9.58e-06 | 165 | 102 | 7 | 2136_UP | |
| Disease | cerebrospinal fluid clusterin measurement | 6.00e-06 | 35 | 100 | 4 | EFO_0007657 | |
| Disease | fibromyalgia (is_marker_for) | 3.40e-05 | 3 | 100 | 2 | DOID:631 (is_marker_for) | |
| Disease | nephrotic syndrome (is_implicated_in) | 1.13e-04 | 5 | 100 | 2 | DOID:1184 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.13e-04 | 139 | 100 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Lissencephaly | 1.69e-04 | 6 | 100 | 2 | C0266463 | |
| Disease | Cockayne syndrome (implicated_via_orthology) | 1.69e-04 | 6 | 100 | 2 | DOID:2962 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia (is_implicated_in) | 3.14e-04 | 8 | 100 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | Henoch-Schoenlein purpura (is_implicated_in) | 3.14e-04 | 8 | 100 | 2 | DOID:11123 (is_implicated_in) | |
| Disease | anterior uveitis (is_implicated_in) | 3.14e-04 | 8 | 100 | 2 | DOID:1407 (is_implicated_in) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 3.16e-04 | 39 | 100 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 3.94e-04 | 42 | 100 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | alopecia areata (is_implicated_in) | 4.03e-04 | 9 | 100 | 2 | DOID:986 (is_implicated_in) | |
| Disease | linoleic acid measurement | 4.38e-04 | 186 | 100 | 5 | EFO_0006807 | |
| Disease | cardiovascular system disease (is_marker_for) | 5.03e-04 | 10 | 100 | 2 | DOID:1287 (is_marker_for) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 5.03e-04 | 10 | 100 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Graves ophthalmopathy (is_implicated_in) | 5.03e-04 | 10 | 100 | 2 | DOID:0081120 (is_implicated_in) | |
| Disease | response to carboplatin, response to antineoplastic agent | 5.03e-04 | 10 | 100 | 2 | GO_0097327, GO_0097328 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 5.68e-04 | 197 | 100 | 5 | EFO_0005680 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 6.13e-04 | 11 | 100 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | antihyperlipidemic drug use measurement | 6.44e-04 | 115 | 100 | 4 | EFO_0803367 | |
| Disease | Leigh disease (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:3652 (implicated_via_orthology) | |
| Disease | Bronchial Hyperreactivity | 7.34e-04 | 12 | 100 | 2 | C0085129 | |
| Disease | anxiety disorder, stress-related disorder | 7.34e-04 | 12 | 100 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | hyperglycemia (is_marker_for) | 8.66e-04 | 13 | 100 | 2 | DOID:4195 (is_marker_for) | |
| Disease | Graves ophthalmopathy (is_marker_for) | 8.66e-04 | 13 | 100 | 2 | DOID:0081120 (is_marker_for) | |
| Disease | Myasthenia gravis | 8.66e-04 | 13 | 100 | 2 | EFO_0004991 | |
| Disease | Bardet-Biedl Syndrome | 8.66e-04 | 13 | 100 | 2 | C0752166 | |
| Disease | Hyperlipoproteinemia Type IIb | 8.66e-04 | 13 | 100 | 2 | C1704417 | |
| Disease | docosahexaenoic acid measurement | 9.33e-04 | 127 | 100 | 4 | EFO_0007761 | |
| Disease | anti-basement membrane glomerulonephritis (implicated_via_orthology) | 1.01e-03 | 14 | 100 | 2 | DOID:4780 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (is_implicated_in) | 1.02e-03 | 58 | 100 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | Endometrial Neoplasms | 1.02e-03 | 58 | 100 | 3 | C0014170 | |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 1.16e-03 | 15 | 100 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.24e-03 | 62 | 100 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | ceramide measurement | 1.25e-03 | 235 | 100 | 5 | EFO_0010222 | |
| Disease | Hyperlipoproteinemia Type IIa | 1.32e-03 | 16 | 100 | 2 | C0745103 | |
| Disease | temporal arteritis (is_implicated_in) | 1.32e-03 | 16 | 100 | 2 | DOID:13375 (is_implicated_in) | |
| Disease | pulmonary fibrosis (is_implicated_in) | 1.32e-03 | 16 | 100 | 2 | DOID:3770 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.48e-03 | 144 | 100 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.50e-03 | 17 | 100 | 2 | C2936862 | |
| Disease | lupus nephritis (is_marker_for) | 1.50e-03 | 17 | 100 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | graft-versus-host disease (is_implicated_in) | 1.50e-03 | 17 | 100 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | stem Cell Factor measurement | 1.55e-03 | 67 | 100 | 3 | EFO_0008291 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.55e-03 | 67 | 100 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | late-onset myasthenia gravis | 1.68e-03 | 18 | 100 | 2 | EFO_1001490 | |
| Disease | Bardet-Biedl syndrome | 1.68e-03 | 18 | 100 | 2 | cv:C0752166 | |
| Disease | Hypercholesterolemia, Familial | 1.68e-03 | 18 | 100 | 2 | C0020445 | |
| Disease | Sjogren's syndrome (is_implicated_in) | 1.68e-03 | 18 | 100 | 2 | DOID:12894 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.85e-03 | 153 | 100 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | cerebral infarction (is_marker_for) | 1.87e-03 | 19 | 100 | 2 | DOID:3526 (is_marker_for) | |
| Disease | Endometrial Carcinoma | 1.90e-03 | 72 | 100 | 3 | C0476089 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 1.90e-03 | 72 | 100 | 3 | DOID:9744 (is_marker_for) | |
| Disease | coronary artery disease | ZHX3 ABCA1 CCDC30 APOB PTPRO GIGYF2 PLCG2 DENND5A FGD6 BICC1 PLCE1 | 2.40e-03 | 1194 | 100 | 11 | EFO_0001645 |
| Disease | colorectal carcinoma (is_implicated_in) | 2.51e-03 | 22 | 100 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | progression free survival, ovarian serous carcinoma | 2.51e-03 | 22 | 100 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Rheumatoid Arthritis | 2.95e-03 | 174 | 100 | 4 | C0003873 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.99e-03 | 24 | 100 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Behcet Syndrome | 2.99e-03 | 24 | 100 | 2 | C0004943 | |
| Disease | interstitial lung disease (is_marker_for) | 3.24e-03 | 25 | 100 | 2 | DOID:3082 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFDNESSNKTWMKNT | 106 | P23470 | |
| KTWELANNMQEAQSI | 11 | Q92905 | |
| SQAMKKWVQGNTDEA | 616 | O43572 | |
| DNSNMTFDKWTDQDD | 106 | Q8IX05 | |
| MTGLDTKNNVKVWFN | 1581 | O95477 | |
| TTKSWKPSSEQMDQD | 316 | P20309 | |
| KKDNWNVSNVLMTFT | 2751 | Q86UQ4 | |
| QMDIENSFITKWKDT | 1306 | Q8WZ64 | |
| FFQKIMEETNTQIAW | 76 | Q9H694 | |
| AQFQTSQFWIMEKTK | 281 | Q8TAM1 | |
| SQAQTEAFWENKQME | 1161 | Q03468 | |
| NTKLWAQMQIDKASE | 456 | Q9H6Z4 | |
| TDEKSFENIQNWMKS | 91 | P51153 | |
| FENIQNWMKSIKENA | 96 | P51153 | |
| SFDKNADTTMKWQTK | 386 | Q9Y2R2 | |
| KDDYMISKDNWNNVN | 436 | Q9NWS1 | |
| TDTWKEMLKFQDATA | 491 | Q9UJ83 | |
| MKSDQESNNAAAEWK | 406 | P02708 | |
| KWTEEFNMEETQTSL | 1121 | P20585 | |
| AMEKTKQEQQASCTW | 686 | O14936 | |
| VKEWEKVFEMSQDKN | 331 | Q14566 | |
| KGNSATEEEIWKFMN | 211 | P43366 | |
| TDNTWMFKDSTEEKS | 1681 | Q9BY89 | |
| MTFAWKKDNEVLTNA | 526 | Q96JA1 | |
| SEDSMKDAWGQVKNY | 406 | P19878 | |
| NSTSWMEVNFAKNRK | 166 | Q8NI17 | |
| DKDMVQSKLDFSQVW | 5576 | Q03001 | |
| WNEQSTKFMDQKNSL | 1711 | Q6ZU64 | |
| FVDKTEWIKSLMNNS | 691 | Q5VYK3 | |
| KNTKNEDLWDSMASI | 471 | Q9NZ08 | |
| NMENKTTWFSVDIDS | 966 | P26006 | |
| KWKSMSNENDIITHF | 766 | Q9ULK4 | |
| DTKENNMKYWEKNQS | 911 | P16885 | |
| QDATSWMEANQKKLV | 151 | P52756 | |
| NDQCQEMDTTTDKWV | 221 | A8MWY0 | |
| KVENLEQDNGWKSMS | 336 | Q8NFU5 | |
| VSMLQEFWESKQQQK | 31 | Q8N485 | |
| SIDEMNNAWENLNKT | 6086 | Q9UPN3 | |
| ETRNDFWKMVLQQKS | 1016 | Q16827 | |
| NQTLMGQTSQVDWKD | 506 | Q9UHC9 | |
| FEWNTGTNVDTKKMT | 1176 | P04114 | |
| KVAQDNMDVFKDQWE | 476 | P26232 | |
| TKNSNMGFWDDAVKE | 1071 | Q6Y7W6 | |
| QAWEQETKLGNESSM | 1026 | O15078 | |
| KWVQDSMDHLDKQTQ | 81 | P13500 | |
| RSNWKFNSVEKIAMS | 126 | Q8NCQ5 | |
| WFAKLQTQMDQDEGT | 111 | Q96JB2 | |
| EMWISSFEQSKKEAQ | 441 | Q6P4F1 | |
| DSSKTTQKWEMNNIH | 641 | Q86SF2 | |
| TNQDVKLDWMFKSSL | 636 | P51841 | |
| SLLWTETFMNKENQN | 931 | P06756 | |
| GTTAKEEMERFWNKN | 31 | Q99643 | |
| NSEKKMESEEDSNWE | 16 | Q9H4A5 | |
| MSQEKNEMFESEWSK | 1 | Q5VVM6 | |
| QEMNTFISLWKEKTN | 111 | Q6TDU7 | |
| KDWCKENFVNSKNMT | 576 | Q9H6R0 | |
| NKTWKEMRATQEDFD | 451 | Q96BJ8 | |
| DKESWFTNREQMQNF | 541 | Q6IQ26 | |
| EAWQSKEEMENTKKF | 161 | Q8NA03 | |
| WTKKDSNMVLSNSNQ | 341 | Q96J84 | |
| KSSKMQAFRIWDVNQ | 31 | P18510 | |
| KDNMKYASWAASQIN | 251 | Q15006 | |
| NSAVSVEQWKAQFKM | 366 | P19447 | |
| SFEKAKESWEMNSEE | 251 | Q02790 | |
| TLFDQVNSNWKAIMD | 1471 | Q9P225 | |
| YWEADSQNETEKMKV | 1741 | Q7Z5N4 | |
| GKQKWFMKQNTEEST | 526 | Q9ULF5 | |
| VNNTKKWKMEFDTRE | 91 | O43181 | |
| KQEDSIWTFAGNMNA | 121 | Q8WYK1 | |
| TKNDTVWDLNMYKSE | 156 | Q9NYW0 | |
| TIKMNESDAWFEEKQ | 296 | O60749 | |
| ATMKQEQKSWEHQSA | 1741 | Q8N4C6 | |
| VSDENSNEKCWEKIM | 81 | Q9P212 | |
| NNWSEKNVSEQMTNE | 371 | Q9H9A7 | |
| NQYEDKTTNMWEKIS | 471 | Q8IVG5 | |
| MEKDDDFTTWTQLAK | 581 | Q8WZA1 | |
| DQVKDRGQWTNKMEF | 31 | P48065 | |
| SFKMWSKLNNEEHNE | 161 | Q13546 | |
| FSAKSAEEKNNWMAA | 526 | Q07889 | |
| WQSMFQKNKEDLRAT | 571 | Q9P2M7 | |
| FLSDDVQTWQESKMA | 146 | Q5QGZ9 | |
| QDSNVNEEWKSMFGS | 851 | Q99570 | |
| KEMTKWNSNDFIDAF | 366 | O00562 | |
| KMEKSNTNWVDITQD | 21 | Q5VZE5 | |
| LKSEWQSMTQESFQE | 391 | Q9UH99 | |
| SIQKWQFSMSAIKEE | 596 | O14776 | |
| WKKESQQDNGDKVMS | 96 | P49675 | |
| TEQVDNWMSKQEAFL | 476 | Q13813 | |
| KFWSQEKNMLVQESQ | 651 | O94964 | |
| KTQELEWQNSSSMED | 771 | Q6ZV73 | |
| KSQQPMKSDDDWSVF | 106 | Q9HBJ7 | |
| DMDQDEKSFWLSQSN | 1041 | Q8WWQ8 | |
| KASALNNWCEKMEEN | 2051 | P02549 | |
| MQQVKRWSDIQKDSF | 91 | Q9BY64 | |
| KTQMSSQQVKQWFAE | 871 | Q9H4I2 | |
| SQQVKQWFAEKMGEE | 876 | Q9H4I2 | |
| NWKLTKLNEMNDSQV | 401 | O95405 | |
| QDDENNSEMSKDWQK | 351 | Q8TEY7 | |
| ADKMWPENEKASSQQ | 141 | Q5JNZ3 | |
| GSQEDFTQVWNTTMK | 131 | O60635 | |
| DRNSTWKADMNDKFT | 176 | A8MPX8 | |
| WKADMNDKFTVVSNF | 181 | A8MPX8 | |
| QNLQWLKEEMETKFS | 556 | Q5VU43 | |
| WVQKTSEMNTDKQYF | 346 | Q96D46 | |
| KNMQNAEEWFKSRFT | 271 | P07196 | |
| MVSQNDGSFISKKEW | 501 | Q15223 |